A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer

BACKGROUND: The clinical behavior of prostate cancer (PCa) is variable, and while the majority of cases remain indolent, 10% of patients progress to deadly forms of the disease. Current clinical predictors used at the time of diagnosis have limitations to accurately establish progression risk. Here...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Georgescu, Constantin, Corbin, Joshua M., Thibivilliers, Sandra, Webb, Zachary D., Zhao, Yan D., Koster, Jan, Fung, Kar-Ming, Asch, Adam S., Wren, Jonathan D., Ruiz-Echevarría, Maria J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6503380/
https://ncbi.nlm.nih.gov/pubmed/31060542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5592-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky